Table 3 Prevalence of the tnpA , tnpB , and cagA genes in the four patient groups
From: Clinical relevance of the cagA, tnpA and tnpB genes in Helicobacter pylori
Disease groups | tnpA | tnpB | cagA | ||||||
|---|---|---|---|---|---|---|---|---|---|
Positives | Relative risk | 95% CI | Positives | Relative risk | 95% CI | Positives | Relative risk | 95% CI | |
Gastritis (n = 95) (Control group) | 40 (42.1%) | Reference | 16 (16.8%) | Reference | 45 (47.4%) | Reference | |||
Gastric ulcer (n = 92) | 48 (52.2%) | 1.23 | 0.97-1.61 | 10 (10.9%) | 0.64 | 0.30-1.34 | 45 (48.9%) | 1.03 | 0.76-1.39 |
Duodenal ulcer (n = 108) | 44 (40.7%) | 0.96 | 0.69-1.34 | 11 (10.2%) | 0.59 | 0.29-1.22 | 67 (62%) | 1.30 | 1.01-1.69 |
Gastric cancer (n = 65) | 39 (60.0%) | 1.45 | 1.04-1.93 | 10 (15.4%) | 0.91 | 0.44-1.88 | 56 (86.2%) | 1.81 | 1.44-2.29 |